Dr. Gillian Cannon Joins Lindus Therapeutics’ Board as a Non-Executive Director

BOSTON, Sept. 08, 2026 (GLOBE NEWSWIRE) — Lindus Therapeutics, a next-generation drug development company advancing a portfolio of in-licensed assets, has announced the appointment of Dr. Gillian Cannon to its board of directors as a non-executive director. Dr. Cannon brings more than 30 years of commercial leadership experience in the biopharmaceutical industry, particularly at Merck […]